These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Studies on the mechanism of action of orinase (tolbutamide). VAUGHAN M Diabetes; 1957; 6(1):16-8; discussion, 19-20. PubMed ID: 13397412 [No Abstract] [Full Text] [Related]
3. Role of the adrenal in response of rats to orinase. DULIN WE; MORLEY EH; NEZAMIS JE Proc Soc Exp Biol Med; 1956 Oct; 93(1):133-6. PubMed ID: 13370600 [No Abstract] [Full Text] [Related]
4. Antibacterial properties of orinase in infected mice. LEWIS C Proc Soc Exp Biol Med; 1957 Apr; 94(4):772-4. PubMed ID: 13431950 [No Abstract] [Full Text] [Related]
5. Hypoglycemic action of orinase, effect on output of glucose by liver. ANDERSON GE; PERFETTO AJ; TERMINE CM; MONACO RR Proc Soc Exp Biol Med; 1956 Jun; 92(2):340-5. PubMed ID: 13350341 [No Abstract] [Full Text] [Related]
6. Clinical use of tolbutamide (orinase) in office and home care of diabetics. BRENEMAN JC J Am Med Assoc; 1957 Jun; 164(6):627-33. PubMed ID: 13428534 [No Abstract] [Full Text] [Related]
7. Some observations on the mode of action of orinase. ARAI Y; ELRICK H; HLAD C; PRATT E; PURNELL R Metabolism; 1956 Nov; 5(6 Part 2):778-87. PubMed ID: 13378047 [No Abstract] [Full Text] [Related]
8. Some effects of orinase in the rat. LANG S; SHERRY S Metabolism; 1956 Nov; 5(6 Part 2):733-8. PubMed ID: 13378040 [No Abstract] [Full Text] [Related]
9. Comparative effects of insulin and orinase on blood levels of pyruvate and alpha-ketoglutarate in normal subjects. CONN JW; FAJANS SS; HENNES AR; WAJCHENBERG BL Metabolism; 1957 Jan; 6(1):63-9. PubMed ID: 13386969 [No Abstract] [Full Text] [Related]
10. Acute effects of orinase on peripheral glucose utilization. GILBERTSEN AS; GOETZ FC; JOSEPHSON V Metabolism; 1956 Nov; 5(6 Part 2):788-800. PubMed ID: 13378048 [No Abstract] [Full Text] [Related]
11. Observations on the action of tolbutamide. ANDERSON GE; MONACO RN; PERFETTO AJ; TERMINE CM Diabetes; 1957; 6(1):34-40; discussion, 43-5. PubMed ID: 13397419 [No Abstract] [Full Text] [Related]
12. Physiologic actions of orinase and their relationship to the types of diabetes in man. KARK RM; MOORHOUSE JA Metabolism; 1956 Nov; 5(6 Part 2):847-63. PubMed ID: 13378054 [No Abstract] [Full Text] [Related]
13. The use of orinase in diabetes. BEASER SB Metabolism; 1956 Nov; 5(6 Part 2):933-9. PubMed ID: 13378062 [No Abstract] [Full Text] [Related]
14. Metabolic effects of orinase in diabetes including two cases complicated by other endocrinopathies; preliminary report. DIRAIMONDO VC; FORSHAM PH; MORTIMORE GE Metabolism; 1956 Nov; 5(6 Part 2):840-6. PubMed ID: 13378053 [No Abstract] [Full Text] [Related]
15. The action of a sulfonylurea hypoglycemic agent (orinase) in extrahepatic tissues. BRITTON B; GRABOWSKI R; WICK AN Metabolism; 1956 Nov; 5(6 Part 2):739-43. PubMed ID: 13378041 [No Abstract] [Full Text] [Related]
16. Hypoglycemic actions of tolbutamide and carbutamide. TUCKER BW; WILLIAMS RH Metabolism; 1956 Nov; 5(6 Part 2):801-6. PubMed ID: 13378049 [No Abstract] [Full Text] [Related]
17. Clinical experience and experimental studies with tolbutamide. CRAIG JW; MILLER M Diabetes; 1957; 6(1):77-9; discussion, 85-90. PubMed ID: 13397433 [No Abstract] [Full Text] [Related]
18. Effects of tolbutamide and carbutamide on thyroid function. BROWN J; SOLOMON DH Metabolism; 1956 Nov; 5(6 Part 2):813-9. PubMed ID: 13378051 [No Abstract] [Full Text] [Related]